Literature DB >> 27145507

High ambient temperature and risk of intestinal obstruction in cystic fibrosis.

Chee Y Ooi1,2, Christina Jeyaruban1, Jasmine Lau1, Tamarah Katz3, Angela Matson4,5, Scott C Bell4,6, Susan E Adams1,7, Usha Krishnan1,2.   

Abstract

AIMS: Distal intestinal obstruction syndrome (DIOS) and constipation in cystic fibrosis (CF) are conditions associated with impaction and/or obstruction by abnormally viscid mucofaecal material within the intestinal lumen. Dehydration has been proposed as a risk factor for DIOS and constipation in CF. The study primarily aimed to determine whether warmer ambient temperature and lower rainfall are risk factors for DIOS and constipation in CF.
METHODS: Hospitalisations for DIOS (incomplete or complete) and/or constipation were retrospectively identified (2000-2012). Genotype, phenotype, temperatures and rainfall data (for the week preceding and season of hospitalisation) were collected.
RESULTS: Twenty-seven DIOS (59.3% incomplete; 40.7% complete) and 44 constipation admissions were identified. All admitted patients were pancreatic insufficient. Meconium ileus was significantly more likely in DIOS than constipation (64.7% vs. 33.3%; P = 0.038) and in complete than incomplete DIOS (100% vs. 57.1%; P = 0.04). The maximum temperature of the week before DIOS admission (mean (standard deviation) = 28.0 (5.8) °C) was significantly higher than the maximum temperature of the season of admission (25.2 (3.4) °C; P = 0.002). Similarly, the maximum temperature of the week before hospitalisation for constipation (mean (standard deviation) = 27.9 (6.3) °C) was significantly warmer compared with the season of admission (24.0 (4.1) °C; P < 0.0001). There were no significant differences between levels of rainfall during the week before hospitalisation and the season of admission for both DIOS and constipation.
CONCLUSIONS: Relatively high ambient temperature may play a role in the pathogenesis of DIOS and constipation in CF.
© 2016 The Authors Journal of Paediatrics and Child Health © 2016 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Keywords:  child; constipation; cystic fibrosis; dehydration; intestinal obstruction; temperature

Mesh:

Year:  2016        PMID: 27145507     DOI: 10.1111/jpc.13096

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  5 in total

Review 1.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

2.  Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations.

Authors:  Tavs Qvist; Daniela K Schlüter; Vian Rajabzadeh; Peter J Diggle; Tania Pressler; Siobhán B Carr; David Taylor-Robinson
Journal:  J Cyst Fibros       Date:  2018-10-19       Impact factor: 5.482

Review 3.  A comprehensive overview of the cystic fibrosis on the island of São Miguel (Azores, Portugal).

Authors:  Joana Rosa; Patrícia Gaspar-Silva; Paula Pacheco; Conceição Silva; Cláudia C Branco; Barbara S Vieira; Alexandra Carreiro; Juan Gonçalves; Luisa Mota-Vieira
Journal:  BMC Pediatr       Date:  2020-01-03       Impact factor: 2.125

4.  Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies.

Authors:  Marina A Stefano; Rosana E Poderoso; Jochen G Mainz; Jose D Ribeiro; Antonio F Ribeiro; Elizete Aparecida Lomazi
Journal:  J Pediatr (Rio J)       Date:  2020-05-08       Impact factor: 2.990

5.  Distal intestinal obstruction syndrome: a diagnostic and therapeutic challenge in cystic fibrosis.

Authors:  Natascha S Sandy; Lilian H P Massabki; Aline C Gonçalves; Antonio F Ribeiro; Jose D Ribeiro; Maria de Fátima C P Servidoni; Elizete A Lomazi
Journal:  J Pediatr (Rio J)       Date:  2019-10-22       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.